MedCity News
MARCH 7, 2025
J&J said aticaprant showed insufficient efficacy in a Phase 3 test in major depressive disorder. The disappointing result follows the Phase 3 failure of a Neumora Therapeutics drug that addresses the same central nervous system target. The post Johnson & Johnson Discontinues Pivotal Depression Drug Trial Due to Lack of Efficacy appeared first on MedCity News.
PharmaVoice
MARCH 10, 2025
Familiar foes in the industry have claimed a slew of jobs in recent months.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma IQ
MARCH 5, 2025
Discover how AI is transforming pharma supply chains in 2025. Learn about AI-driven productivity gains and machine learning for inventory management.
Evolve Your Success
MARCH 5, 2025
Struggling to stand out in medical sales? This episode is your blueprint for crafting a resume that gets noticed, even if you don’t have direct sales experience. Learn how to position your background as an asset, highlight your sales potential, and structure your resume for maximum impact. We’ll also dive into LinkedIn strategies to boost your visibility and connect with decision-makers, plus real success stories from professionals who made the leap.
Speaker: Jesse Hunter and Brynn Chadwick
Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.
pharmaphorum
MARCH 5, 2025
The FDA has approved the first generic versions of Johnson & Johnson's big-selling anticoagulant Xarelto
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
PharmaVoice
MARCH 4, 2025
Voyager Therapeutics’ progress with drug candidates targeting tau marks a step in how the industry is walking multiple paths toward new therapeutic options.
PharmaTimes
MARCH 6, 2025
Octapharma supports NHS in building resilient supply chain
Pharmaceutical Technology
MARCH 4, 2025
AstraZeneca's Imfinzi (durvalumab) plus chemotherapy, has gained CHMP recommendation for approval in the EU to treat NSCLC.
pharmaphorum
MARCH 7, 2025
An observational study backed by Biogen has suggested that Apple smartphones and watches may be able to spot the signs of mild cognitive impairment
Advertiser: ZoomInfo
Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.
MedCity News
MARCH 5, 2025
Through the collaboration, Bicycle Health and Wellpath are able to offer virtual opioid use disorder support to those in residential reentry centers. The post Bicycle Health, Wellpath Ink Additional OUD Treatment Contract with Federal Bureau of Prisons appeared first on MedCity News.
PharmaVoice
MARCH 4, 2025
A recent study revealed the key barriers to enrollment and how pharma can help turn the tide.
PharmaTimes
MARCH 5, 2025
Cohort expansion phase commences with promising results
Pharmaceutical Technology
MARCH 4, 2025
ADCs are currently at the forefront of cancer treatment, but persistent drug development challenges call for a new approach.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
pharmaphorum
MARCH 6, 2025
In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Bryan Hill, life sciences chief technology officer at Cognizant, in a conversation on how generative AI is revolutionising life sciences and drug development.
MedCity News
MARCH 9, 2025
Providing affordable point-of-care diagnostic tools can be instrumental in quickly and efficiently assessing the well-being of all people, especially pregnant mothers. This can empower healthcare providers to be better diagnosticians and improve overall patient care, particularly for those at risk. The post Navigating Diagnostic Deserts: How Portable Ultrasound is Improving Maternal Healthcare in Africa appeared first on MedCity News.
PharmaVoice
MARCH 5, 2025
The company's vice president and general manager of U.S. business operations explains how Amgen is going to deliver on its “ambitious growth aspirations.
PharmaTimes
MARCH 5, 2025
Innovative digital transformation leads to significant improvements
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Quantified
MARCH 5, 2025
Sales teams today need training that feels real, moves fast, and delivers measurable results. Thats why were introducing major enhancements to Quantified’s AI role play technology giving sales reps a more lifelike, adaptive, and effective way to practice their conversations. The latest updates focus on three critical areas: Faster deployment Get AI avatars up and running in less time, reducing training delays More realistic interactions Improved responsiveness and expressiveness make AI
pharmaphorum
MARCH 5, 2025
FDA starts a review of Roche's Gazyva as a treatment for lupus nephritis, an indication that analysts think could unlock renewed sales growth
MedCity News
MARCH 5, 2025
Wegovy will ship directly to eligible patients through NovoCare, an online pharmacy established by Novo Nordisk. The products price matches a recent price cut for Zepbound offered by Eli Lilly through its own direct-to-patient online platform. The post Novo Nordisk Launches Lower-Cost Wegovy, Following Eli Lilly Into Direct-to-Patient Sales appeared first on MedCity News.
PharmaVoice
MARCH 10, 2025
Experts say cost and other barriers present challenges to returning to U.S. shores.
PharmaTimes
MARCH 6, 2025
NICE convenes third committee meeting for additional appraisal consideration
Pharmaceutical Technology
MARCH 4, 2025
Callio Therapeutics has raised $187m in Series A financing round for achieving clinical proof-of-concept for HER2-targeted dual-payload ADC.
pharmaphorum
MARCH 4, 2025
Eli Lilly has used an Oscars ad to urge people not to use unapproved and untested weight-loss medicines in a swipe at the compounding sector
MedCity News
MARCH 6, 2025
[Sponsored] Mayo Clinic Platform has developed a new program that could help speed up the time it takes for digital health startups to succeed. The post Mayo Clinic Program Wants to Help Digital Health Startups Grow appeared first on MedCity News.
Speaker: Kevin Burke
AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.
PharmaVoice
MARCH 10, 2025
Even the most advanced medical devices can fail patients if used incorrectly. These are the most common errors.
PharmaTimes
MARCH 4, 2025
Lead candidate for lung infections moves to human trials
Pharmaceutical Technology
MARCH 7, 2025
NICE previously rejected Leqembi and Kisunla for NHS coverage in August and October 2024, respectively.
Expert insights. Personalized for you.
274 
Let's personalize your content